ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Proteinuria"

  • 2017 American Transplant Congress

    Early Introduction of Oral Paricalcitol in Renal Transplant Recipients. An Open-Label Randomized Study.

    H. Pihlstrøm,1 F. Gatti,2 C. Hammarstrom,2 I. Eide,1 M. Kasprzycka,2 J. Wang,2 G. Haraldsen,2 M. Svensson,3 K. Midtvedt,1 A. Hartmann,1 G. Mjøen,1 D. Dahle,1 H. Holdaas.1

    1Department of Surgery, Inflammation Medicine and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway; 2Department of Pathology, Oslo University Hospital Rikshospitalet, Oslo, Norway; 3Department of Nephrology, Akershus University Hospital, Oslo, Norway

    In stable renal transplant recipients with hyperparathyroidism, the vitamin D agonist paricalcitol reduces level of proteinuria. Animal studies indicate possible anti-fibrotic and anti-inflammatory effects. The…
  • 2016 American Transplant Congress

    Effect of Isolated Intraperitoneal Sirolimus Treatment on the Kidneys of C57BL/6 Mice.

    B. Kim,1,3 Y. Cho,3 H. Lee,3 D. Joo,2,3 K. Huh,2,3 M. Kim,2,3 Y. Kim.2,3

    1Nephrology Division, Department of Internal Medicine, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea; 2Department of Transplantation Surgery, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea; 3The Research Institute for Transplantation, Seoul, Republic of Korea.

    Sirolimus, a mammalian target of rapamycin inhibitor, is widely used in transplantation. However, the mechanism by which sirolimus induces adverse effects such as proteinuria and…
  • 2016 American Transplant Congress

    Correlation of the Shear Wave Elastography with Renal Function in Kidney Transplant Recipients: A Proof of Concept Study.

    J. Dosal-Bañuelos, A. Flores-Mendoza, L. Morales-Buenrostro, M. Díaz-Zamudio.

    Radiology and Nephrology, National Institute of Medical Sciences and Nutrition SZ, México, Distrito Federal, Mexico.

    Background: Non-invasive biomarker for kidney allograft fibrosis is needed. Shear wave elastography is a relatively new technique to assess tissue stiffness. Graft rejection and chronic…
  • 2016 American Transplant Congress

    Only 13% of Liver Transplant (LT) Recipients with Moderate to Severe Kidney Disease (KD) Tolerate Conversion to Everolimus and Reduced Tacrolimus (EVR/rTac).

    S.-H. Pan, I. Kim, A. Klein, A. Annamalai, T. Todo, N. Nissen.

    Liver Transplant, Cedars-Sinai Medical Center, Los Angeles, CA.

    EVR/rTac has been reported to improve renal function in LT recipients with adequate kidney function (eGFR > 80ml/min); however, this strategy in LT patients with…
  • 2016 American Transplant Congress

    Effect of Baseline Proteinuria on Long- and Short-Term Outcomes in Live Kidney Donors – 10 Year U.K Cohort Study.

    N. Krishnan,1 L. Bradbury,2 N. Raymond.1

    1Renal & Transplantation, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, United Kingdom; 2Statistics, National Health Service, Organ Donation & Transplant, Bristol, United Kingdom.

    Living kidney donation has significantly improved recipient and graft survival world wide. It is importanat to have a better understanding of the outcomes and risks…
  • 2016 American Transplant Congress

    Is There a Link Between Proteinuria and Increased FGF-23 Levels in Renal Transplant Patients.

    E. Tutal,1 S. Sezer,1 Z. Bal,1 B. Demirci,1 M. Haberal.2

    1Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey; 2General Surgery, Baskent University Faculty of Medicine, Ankara, Turkey.

    Purpose: Fibroblast growth factor 23 (FGF23) has emerged as a risk factor for cardiovascular disease and mortality in renal transplant (RT) recipients. Post transplantation proteinuria…
  • 2016 American Transplant Congress

    Association of Genetic Polymorphisms of Angiopoietin-Like 4 with Proteinuria in Kidney Allograft Recipients.

    Y. Chang,1,4 T. Shah,2,4 Y.-T. Chuang,3 D. Min.4

    1Mendez National Institute of Transplantation Foundation, Los Angeles, CA; 2St. Vincent Medical Center, Los Angeles, CA; 3Taipei medical university, Taipei, Taiwan; 4Western University of Health Sciences, Pomona.

    Background: Proteinuria is a hallmark of glomerular injury, and persistent proteinuria is associated with graft failure in kidney transplant patients. Recently, it is known that…
  • 2016 American Transplant Congress

    Impact of Early Calcineurin Inhibitor Withdrawal on Renal Function and Urinary Protein Excretion: 24 Month Analyses of the ELEVATE Study.

    J. de Fijter,1 H. Holdaas,1 M. Seelen,1 S. Sundar,1 F. Bemelman,1 P. Lopez,2 J. Aguilar,2 P. Bernhardt,2 Z. Wang,3 J. Cruzado,1 M. van der Giet.1

    1ELEVATE study group, Leiden, Netherlands; 2Novartis, Basel, Switzerland; 3Novartis Pharmaceutical Corporation, East Hanover, NJ.

    Background: Proteinuria is a biomarker which helps in predicting graft outcomes in kidney transplant recipients (KTxRs). The ELEVATE study was designed to determine whether an…
  • 2016 American Transplant Congress

    Pulse Pressure and GFR Decay in Kidney Transplant Recipients.

    O. Sanchez, S. Reule, R. Spong, N. Issa, A. Kukla, A. Matas, H. Ibrahim.

    U of MN, Mpls.

    Single blood pressure values have commonly been used to assess the risk of allograft failure in kidney transplant recipients. In this analysis we prospectively evaluated…
  • 2016 American Transplant Congress

    Analysis of FSGS (Focal Segmental Glomerulosclerosis) Recurrence After Renal Transplantation.

    J. Mansur, G. Basso, M. Cristelli, G. Mata, T. Sandes-Freitas, G. Kirsztajn, H. Tedesco-Silva, J. Medina-Pestana.

    Nephrology-Division, Hospital do Rim - UNIFESP, São Paulo, Brazil.

    Purpose: To describe clinical-laboratorial profile and outcome of patients diagnosed with recurrent FSGS submitted to plasmapheresis.Methods: Retrospective single-center cohort study including all patients with recurrent…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences